BB Biotech AG: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Directors Deals Ltd.
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
BB Biotech AG to Distribute FY 2012 Dividend
BB Biotech AG announced that its Management Board has decided to distribute the fiscal year 2012 dividend of CHF 4.50 per share. For the fiscal year 2011, the Company did not issue any dividend.
Latest Key Developments in Biotechnology
- Lorus Therapeutics Inc completes $7,001,500 prospectus offering of common shares
- KaloBios Pharmaceuticals Inc announces preliminary phase 1 results in advanced hematologic malignancies with kb004, an anti-epha3 monoclonal antibody
- Zogenix Inc announces FDA approval of four mg SUMAVEL DosePro (sumatriptan injection) needle-free delivery system
- Seattle Genetics Inc highlights ADCETRIS (Brentuximab Vedotin) phase two clinical data in diffuse large B-cell Lymphoma (DLBCL) at ASH 2013
- Share this
- Digg this